NO20062943L - Fremgangsmate for fremstilling av pyrazolo[1,5-alfa]-1,3,5-triaziner og intermediater derav - Google Patents
Fremgangsmate for fremstilling av pyrazolo[1,5-alfa]-1,3,5-triaziner og intermediater deravInfo
- Publication number
- NO20062943L NO20062943L NO20062943A NO20062943A NO20062943L NO 20062943 L NO20062943 L NO 20062943L NO 20062943 A NO20062943 A NO 20062943A NO 20062943 A NO20062943 A NO 20062943A NO 20062943 L NO20062943 L NO 20062943L
- Authority
- NO
- Norway
- Prior art keywords
- intermediates
- preparation
- triazines
- pyrazolo
- alpha
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Cardiology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52505003P | 2003-11-25 | 2003-11-25 | |
US10/985,236 US7208596B2 (en) | 2003-11-25 | 2004-11-10 | Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof |
PCT/US2004/039046 WO2005051954A2 (en) | 2003-11-25 | 2004-11-19 | PROCESSES FOR THE PREPARATION OF PYRAZOLO[1,5-a]-1,3,5-TRIAZINES AND INTERMEDIATES THEREOF |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20062943L true NO20062943L (no) | 2006-08-25 |
Family
ID=34636532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20062943A NO20062943L (no) | 2003-11-25 | 2006-06-23 | Fremgangsmate for fremstilling av pyrazolo[1,5-alfa]-1,3,5-triaziner og intermediater derav |
Country Status (15)
Country | Link |
---|---|
US (2) | US7208596B2 (es) |
EP (1) | EP1706408A2 (es) |
JP (1) | JP2007512360A (es) |
KR (1) | KR20060116208A (es) |
AR (1) | AR046851A1 (es) |
AU (1) | AU2004293435A1 (es) |
BR (1) | BRPI0416821A (es) |
CA (1) | CA2546652A1 (es) |
IL (1) | IL175753A0 (es) |
MX (1) | MXPA06005482A (es) |
NO (1) | NO20062943L (es) |
PE (1) | PE20051045A1 (es) |
RU (1) | RU2006121075A (es) |
TW (1) | TW200529827A (es) |
WO (1) | WO2005051954A2 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7208596B2 (en) * | 2003-11-25 | 2007-04-24 | Bristol-Myers Squibb Pharma Company | Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof |
GB0525068D0 (en) | 2005-12-08 | 2006-01-18 | Novartis Ag | Organic compounds |
US8349852B2 (en) | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
WO2011093352A1 (ja) | 2010-01-27 | 2011-08-04 | 武田薬品工業株式会社 | チアゾール誘導体 |
AR080056A1 (es) | 2010-02-01 | 2012-03-07 | Novartis Ag | Derivados de ciclohexil-amida como antagonistas de los receptores de crf |
AR080055A1 (es) | 2010-02-01 | 2012-03-07 | Novartis Ag | Derivados de pirazolo-[5,1-b]-oxazol como antagonistas de los receptores de crf -1 |
EP2531490B1 (en) | 2010-02-02 | 2014-10-15 | Novartis AG | Cyclohexyl amide derivatives as crf receptor antagonists |
US8546416B2 (en) | 2011-05-27 | 2013-10-01 | Novartis Ag | 3-spirocyclic piperidine derivatives as ghrelin receptor agonists |
EP2852591A1 (en) | 2012-05-03 | 2015-04-01 | Novartis AG | L-malate salt of 2, 7 - diaza - spiro [4.5]dec- 7 - yle derivatives and crystalline forms thereof as ghrelin receptor agonists |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3910907A (en) | 1973-07-09 | 1975-10-07 | Icn Pharmaceuticals | Pyrazolo(1,5-a)-1,3,5-triazines |
US4824834A (en) | 1986-10-31 | 1989-04-25 | Otsuka Pharmaceutical Company, Limited | Pyrazolotriazine compounds |
DE3722072A1 (de) | 1987-07-01 | 1989-01-12 | Schering Ag | 6,7-dihydro-pyrazolo(1,5-a)(1,3,5) triazin-2-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung als mittel mit herbizider und pflanzenwuchsregulierender wirkung |
JP2691317B2 (ja) | 1989-08-25 | 1997-12-17 | 株式会社大塚製薬工場 | 4―ヒドロキシ―8―(3―低級アルコキシ―4―フェニルスルフィニルフェニル)ピラゾロ〔1,5―a〕―1,3,5―トリアジン光学活性体の塩類及びその製造方法 |
US5484760A (en) | 1990-12-31 | 1996-01-16 | Monsanto Company | Herbicide antidotes as safeners for reducing phytotoxicity resulting from synergistic interaction between herbicides and other pesticides |
AU667575B2 (en) | 1992-10-20 | 1996-03-28 | Otsuka Pharmaceutical Co., Ltd. | Condensed pyrazole derivatives, method of manufacturing the same, and androgen inhibitor |
CN1088574A (zh) | 1992-12-24 | 1994-06-29 | 中国科学院化学研究所 | 2,6-二甲基-4-叔丁基-3-硝基-苯乙氰的合成方法 |
US6191131B1 (en) | 1997-07-23 | 2001-02-20 | Dupont Pharmaceuticals Company | Azolo triazines and pyrimidines |
EA006626B1 (ru) | 1996-07-24 | 2006-02-24 | Дюпон Фармасьютикалз Компани | Азолопиримидины, фармацевтическая композиция и способ лечения |
US6124289A (en) | 1996-07-24 | 2000-09-26 | Dupont Pharmaceuticals Co. | Azolo triazines and pyrimidines |
US6060478A (en) * | 1996-07-24 | 2000-05-09 | Dupont Pharmaceuticals | Azolo triazines and pyrimidines |
US6313124B1 (en) | 1997-07-23 | 2001-11-06 | Dupont Pharmaceuticals Company | Tetrazine bicyclic compounds |
HUP9903965A3 (en) | 1996-08-28 | 2002-02-28 | Pfizer | Substituted 6,5-hetero-bicyclic derivatives |
DE59907401D1 (de) * | 1998-12-21 | 2003-11-20 | Lonza Ag | Verfahren zur Herstellung von 2,5-Diamino-4,6-dihalogenpyrimidinen |
EA200200421A1 (ru) | 1999-09-30 | 2002-10-31 | Ньюроджен Корпорейшн | АМИНОЗАМЕЩЕННЫЕ ПИРАЗОЛО[1,5-a]-1,5-ПИРИМИДИНЫ И ПИРАЗОЛО[1,5-a]-1,3,5-ТРИАЗИНЫ |
JP2001302658A (ja) | 2000-04-18 | 2001-10-31 | Showa Denko Kk | 3−イソクロマノン類の製造方法 |
MXPA03008185A (es) * | 2001-03-13 | 2004-01-29 | Bristol Myers Squibb Pharma Co | 4-(2-butilamino)-2, 7-dimetil-8 -(2-metil-6-metoxipirid -3-il) pirazol-[1, 5-a]-1, 3, 5-triazina, sus enantiomeros y sales farmaceuticamente aceptables como ligandos del receptor del factor de liberacion de corticotropina. |
US7208596B2 (en) * | 2003-11-25 | 2007-04-24 | Bristol-Myers Squibb Pharma Company | Processes for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof |
-
2004
- 2004-11-10 US US10/985,236 patent/US7208596B2/en active Active
- 2004-11-19 JP JP2006541577A patent/JP2007512360A/ja active Pending
- 2004-11-19 RU RU2006121075/04A patent/RU2006121075A/ru not_active Application Discontinuation
- 2004-11-19 WO PCT/US2004/039046 patent/WO2005051954A2/en active Application Filing
- 2004-11-19 EP EP04811716A patent/EP1706408A2/en not_active Withdrawn
- 2004-11-19 MX MXPA06005482A patent/MXPA06005482A/es unknown
- 2004-11-19 BR BRPI0416821-6A patent/BRPI0416821A/pt not_active IP Right Cessation
- 2004-11-19 AU AU2004293435A patent/AU2004293435A1/en not_active Abandoned
- 2004-11-19 CA CA002546652A patent/CA2546652A1/en not_active Abandoned
- 2004-11-19 KR KR1020067009566A patent/KR20060116208A/ko not_active Application Discontinuation
- 2004-11-24 AR ARP040104336A patent/AR046851A1/es unknown
- 2004-11-24 TW TW093136179A patent/TW200529827A/zh unknown
- 2004-11-24 PE PE2004001150A patent/PE20051045A1/es not_active Application Discontinuation
-
2006
- 2006-05-18 IL IL175753A patent/IL175753A0/en unknown
- 2006-06-23 NO NO20062943A patent/NO20062943L/no not_active Application Discontinuation
-
2007
- 2007-03-13 US US11/717,440 patent/US7442792B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
AR046851A1 (es) | 2005-12-28 |
CA2546652A1 (en) | 2005-06-09 |
MXPA06005482A (es) | 2006-08-11 |
KR20060116208A (ko) | 2006-11-14 |
TW200529827A (en) | 2005-09-16 |
US20070161790A1 (en) | 2007-07-12 |
US7208596B2 (en) | 2007-04-24 |
AU2004293435A1 (en) | 2005-06-09 |
JP2007512360A (ja) | 2007-05-17 |
EP1706408A2 (en) | 2006-10-04 |
US20050143380A1 (en) | 2005-06-30 |
PE20051045A1 (es) | 2005-12-29 |
WO2005051954A2 (en) | 2005-06-09 |
BRPI0416821A (pt) | 2007-03-06 |
RU2006121075A (ru) | 2008-01-10 |
US7442792B2 (en) | 2008-10-28 |
IL175753A0 (en) | 2006-09-05 |
WO2005051954A3 (en) | 2005-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20062943L (no) | Fremgangsmate for fremstilling av pyrazolo[1,5-alfa]-1,3,5-triaziner og intermediater derav | |
CY1122238T1 (el) | Νεα 1-ναφθυλ-3-αζαδικυκλο[3.1.0]εξανia: παρασκευη και χρηση για τη θεραπεια νευροψυχιατρικων διαταραχων | |
WO2008045393A3 (en) | Imidazo- and triazolo-pyridine compounds and methods of use therof | |
TW200800959A (en) | Piperazine-piperidine antagonists and agonists of the 5-HT1a receptor | |
TW200700068A (en) | Phthalazine, aza-and diaza-phthalazine compounds and methods of use | |
NO20073019L (no) | Pyrasolonforbindelser som metabotrope glutamatreseptor-antagonister for behandlingen av nevrotiske og psykiatriske lidelser | |
DE60215000D1 (de) | DIHYDROPYRROLOi1,2-AöINDOL- UND TETRAHYDROPYRIDOi1,2-AöINDOLDERIVATE ALS PROSTAGLANDIN REZEPTOR ANTAGONISTEN | |
ATE384050T1 (de) | Benzazepinderivate als histamin-h3-antagonisten | |
DE602006021645D1 (de) | Verfahren und Zwischenverbindungen zur Herstellung von N4-Phenyl-Quinazolin-4-Amin Derivaten | |
NO20042141L (no) | Terapeutiske quinolonforbindelser med 5-HT-antagonistiske egenskaper | |
CU20070156A7 (es) | Compuestos de quinolina heteroaromaticos y su uso como inhibidores de pde10 | |
EA200600049A1 (ru) | Способы получения 3 - бензазепинов | |
NO20054005L (no) | Nye arylpiperazinylforbindelser | |
NO20063196L (no) | Nye fusjonerte pyrrolokarbazoler | |
CY1106607T1 (el) | 4-(2-βουτυλαμιονο)-2,7-διμεθυλ-8-(2-μεθυλ-6-μεθοξυπυριδ-3-υλ) πυραζολο-1,5-αι-1,3,5-τριαζινη, τα εναντιομορα και φαρμακευτικως παραδεκτα αλατα αυτης ως συναρμοτες του υποδοχεα του παραγοντος απελευθερωσης κορτικοτροπινης | |
MY153719A (en) | Prokineticin 1 receptor antagonists | |
WO2007079163A3 (en) | Prokineticin 1 receptor antagonists | |
ECSP066474A (es) | Arilindenopiridinas y arilindenopirimidinas y su uso como antagonista del receptor adenosina a2a | |
BR0206513A (pt) | Composição, métodos de tratamento de um ser humano ou animal que sofre de depressão, ansiedade generalizada, distúrbios da alimentação, demência, distúrbio do p nico, distúrbios do sono, distúrbios gastrointestinais, distúrbios motores, distúrbios endócrinos, vasoespasmo e disfunção sexual, uso de qualquer um dos compostos, composição farmacêutica, e, processo para preparar compostos | |
SG157231A1 (en) | Substituted p-diaminobenzene derivatives | |
CY1110711T1 (el) | Παραγωγα πυραζολο [3,4-d]αζεπινης ως ανταγωνιστες ισταμινης η3 | |
NO20052655L (no) | Sammensmeltede heterocykliske forbindelser | |
DK1370268T3 (da) | Fremgangsmåde til behandling af stresssygdomme under anvendelse af glucocorticoid-receptor-specifikke antagonister | |
DE502004011551D1 (de) | 1,3,4-substituierte pyrazole als 5-ht rezeptor-antagonisten zur behandlung von psychosen und neurologischen störungen | |
MXPA05006975A (es) | Compuestos cardiotonicos con actividad inhibidora en contra de receptores beta-adrenergicos y fosfodiesterasa. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |